STOCK TITAN

Ovintiv Inc. Form 4 Filings

OVV NYSE

Every Form 4 that Ovintiv Inc. (OVV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow OVV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OVV filings page.

Rhea-AI Summary

Ovintiv Inc. director Brian Gordon Shaw acquired 190 deferred share units on September 29, 2026, as dividend equivalent units received in lieu of cash dividends for the third quarter of 2026. His reported position after the acquisition was 38,378 deferred share units. Each unit is the economic equivalent of one common share, and the units are held until retirement from the Board.

Rhea-AI Summary

Ovintiv Inc. director Sippy Chhina acquired 16 Deferred Share Units on September 29, 2026. The units were credited as dividend equivalent DSUs in lieu of cash dividends for the third quarter of 2026. Chhina's direct DSU balance following the transaction was 3,204 DSUs.

Rhea-AI Summary

Ovintiv Inc. director Ralph Izzo acquired 39 Deferred Share Units on September 29, 2026, as dividend equivalent units received in lieu of cash dividends for the third quarter of 2026. After the acquisition, his reported direct holding was 7,781 Deferred Share Units. Each unit is the economic equivalent of one Ovintiv common share, yields dividend equivalent DSUs, and is held until retirement from the Board.

Rhea-AI Summary

Ovintiv Inc. director Meg Gentle acquired 62 deferred share units on September 29, 2026, as dividend-equivalent DSUs received in lieu of cash dividends for the third quarter of 2026. Each DSU is the economic equivalent of one common share and yields dividend-equivalent DSUs; the units are held until retirement from the Board. Her reported direct position after the acquisition was 12,447 deferred share units.

Rhea-AI Summary

Ovintiv Inc. director Howard John Mayson acquired 50 Deferred Share Units on September 29, 2026, as dividend-equivalent DSUs received in lieu of cash dividends for the third quarter of 2026. His reported direct holdings after the acquisition were 10,134 DSUs.

Rhea-AI Summary

Ovintiv Inc. director Terri Gay King acquired 4 Deferred Share Units on September 29, 2026. The units were dividend equivalent DSUs received in lieu of cash dividends for the third quarter of 2026; 816 DSUs were reported following the acquisition. Each DSU is the economic equivalent of one share of common stock and yields dividend equivalent DSUs.

Rhea-AI Summary

Ovintiv Inc. EVP, Commercial & Legal Affs. Meghan Nicole Eilers acquired 237 restricted share units on September 29, 2026. These dividend-equivalent RSUs were received in lieu of cash dividends for the third quarter of 2026. Her direct position after the award was 47,192 restricted share units.

Rhea-AI Summary

Rachel Maureen Moore, Ovintiv Inc.’s EVP, Corporate Services, acquired 187 Restricted Share Units on September 29, 2026. The dividend equivalent RSUs were received in lieu of cash dividends for the third quarter of 2026; each RSU is the economic equivalent of one common share. Moore’s reported direct position following the transaction was 37,883 RSUs. Vesting and exercise are subject to continued employment.

Rhea-AI Summary

Ovintiv Inc. (OVV) EVP & CFO Corey Douglas Code acquired 345 restricted share units and 14 deferred share units on September 29, 2026, as dividend-equivalent units in lieu of cash dividends for the third quarter of 2026. After these acquisitions, he held 70,145 restricted share units and 2,893 deferred share units. Each unit is economically equivalent to one common share; the restricted share units follow the underlying vesting schedule subject to continued employment, while deferred share units are held until retirement.

Rhea-AI Summary

Ovintiv Inc. President & CEO Brendan Michael McCracken acquired 1,143 dividend equivalent restricted share units (RSUs) on September 29, 2026, received in lieu of cash dividends for the third quarter of 2026. His reported position following the acquisition was 227,891 RSUs. Each RSU is the economic equivalent of one common share.

Rhea-AI Summary

Ovintiv Inc. EVP & COO Gregory Dean Givens acquired 397 restricted share units on September 29, 2026. The units were dividend-equivalent RSUs received in lieu of cash dividends for the third quarter of 2026. His reported direct position after the transaction was 79,094 restricted share units. Each RSU is economically equivalent to one common share; vesting and exercise follow the Omnibus Incentive Plan and applicable grant agreement schedule, subject to continued employment through the applicable exercise date.

Rhea-AI Summary

Ovintiv Inc. executive Rachel Maureen Moore, EVP Corporate Services, reported selling 7,753 shares of common stock on 2026-08-12 in an open market or private transaction. The shares were sold at $63.32 per share, a U.S. dollar value converted from a sale price of CAD$88.20 per share using the Bank of Canada exchange rate on the transaction date. Following this transaction, Moore directly holds 72,530 shares of Ovintiv common stock.

Rhea-AI Summary

Ovintiv Inc. President & CEO Brendan Michael McCracken exercised 5,098 Stock Appreciation Rights on August 11, 2026 at an exercise price of $22.95 per right, receiving 5,098 shares of common stock. On the same date, he disposed of 5,098 common shares to the issuer at $63.56 per share, and the exercised Stock Appreciation Rights position was reduced to zero. Each Stock Appreciation Right was the economic equivalent of one share of Ovintiv common stock.

Rhea-AI Summary

Ovintiv Inc. President & CEO Brendan Michael McCracken reported an exercise and related disposition of equity-linked awards. On 2026-08-07 he exercised 5,500 Stock Appreciation Rights, each economically equivalent to one share of common stock, at an exercise price of $22.95 per share, receiving 5,500 shares of common stock. That same day, he disposed of 5,500 common shares to the issuer at $59.86 per share. Following the exercise, he reported 5,098 Stock Appreciation Rights remaining.

Rhea-AI Summary

Shaw Brian Gordon reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Brian Gordon Shaw received a grant of 404 Deferred Share Units on July 29, 2026. Each DSU is economically equivalent to one share of common stock, yields dividend-equivalent DSUs, and is held until Board retirement. Following this award, Shaw directly holds 38,188 DSUs.

Rhea-AI Summary

Chhina Sippy reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Sippy Chhina received a grant of 404 Deferred Share Units (DSUs) on July 29, 2026. Each DSU is economically equivalent to one share of common stock and earns dividend-equivalent DSUs, bringing her total DSU holdings to 3,188, held until retirement from the Board.

Rhea-AI Summary

IZZO RALPH reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Ralph Izzo received a grant of 402 Deferred Share Units on 2026-07-29. After this award, he holds 7,742 Deferred Share Units directly. Each DSU is the economic equivalent of one share of Ovintiv common stock, yields dividend-equivalent DSUs, and is held until retirement from the Board. The filing indicates the transaction was not made pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

King Terri Gay reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Terri Gay King received a grant of 402 Deferred Share Units on July 29, 2026. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs held until retirement from the Board. Following this award, King directly holds 812 DSUs.

Rhea-AI Summary

Gentle Meg reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Meg Gentle received a grant of 486 Deferred Share Units on 2026-07-29, increasing her direct DSU holdings to 12,385 units. Each DSU is the economic equivalent of one common share and accumulates dividend-equivalent DSUs that are held until retirement from the Board.

Rhea-AI Summary

IZZO RALPH reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Ralph Izzo received a grant of 41 Deferred Share Units (DSUs) as dividend-equivalent compensation. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs. These units were issued in lieu of cash dividends for the second quarter of 2026 and are held until Mr. Izzo retires from the Board. Following this award, he holds a total of 7,340 DSUs, each linked to an equivalent number of underlying common shares.

Rhea-AI Summary

Chhina Sippy reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Sippy Chhina received 15 Deferred Share Units (DSUs) as a grant tied to second-quarter 2026 cash dividends. Each DSU is economically equivalent to one share of Ovintiv common stock and accumulates dividend equivalents. After this award, Chhina holds 2,784 DSUs, which are retained until retirement from the board and do not represent an open-market share purchase or sale.

Rhea-AI Summary

Givens Gregory Dean reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc.’s EVP & COO Gregory Dean Givens reported a grant of 441 Restricted Share Units (RSUs) tied to common stock. These RSUs are dividend-equivalent units received in lieu of a cash dividend for the second quarter of 2026 under Ovintiv’s Omnibus Incentive Plan.

Each RSU is economically equivalent to one Ovintiv common share and includes dividend-equivalent rights, vesting according to the applicable grant agreement and plan rules, contingent on continued employment. Following this award, Givens directly holds 78,697 RSUs representing compensation-based equity rather than open‑market purchases.

Rhea-AI Summary

Ovintiv Inc. executive Meghan Nicole Eilers received an award of 263 Restricted Share Units (RSUs), including dividend-equivalent RSUs, linked to Ovintiv common stock. These RSUs were granted at no cash cost as compensation and increase her direct holdings to 46,955 shares on an as-converted basis.

The RSUs vest and become exercisable over time under Ovintiv’s Omnibus Incentive Plan and the related grant agreement, and remain subject to her continued employment with the company through the relevant vesting dates.

Rhea-AI Summary

Ovintiv Inc. executive Rachel Maureen Moore, EVP of Corporate Services, received a grant of 208 Restricted Share Units, credited as dividend equivalent RSUs for the second quarter of 2026. Each RSU is economically equivalent to one share of Ovintiv common stock and accrues further dividend equivalents.

The RSUs vest and become exercisable under Ovintiv’s Omnibus Incentive Plan and the related grant terms, contingent on Moore’s continued employment through the applicable exercise date. Following this award, she holds 37,696 RSUs representing compensation-based equity exposure to Ovintiv stock.

Rhea-AI Summary

McCracken Brendan Michael reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc.’s President & CEO Brendan Michael McCracken received a grant of 1,271 Restricted Share Units (RSUs) tied to common stock. These RSUs were issued as dividend equivalent units for the second quarter of 2026 rather than in cash.

Each RSU is economically equal to one Ovintiv common share and will vest and become exercisable under the company’s Omnibus Incentive Plan and the related grant agreement, subject to his continued employment. After this award, his reported directly held RSU-type units increased to 226,748.

Rhea-AI Summary

Gentle Meg reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Meg Gentle reported receiving 67 Deferred Share Units as a grant or award. Each Deferred Share Unit is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent DSUs. The award reflects dividend equivalent DSUs received in lieu of cash dividends for the second quarter of 2026. Following this grant, Gentle holds a total of 11,899 Deferred Share Units, which are held until retirement from the Board.

Rhea-AI Summary

Ovintiv Inc. EVP & CFO Corey Douglas received equity-based compensation awards. He acquired 386 Restricted Share Units and 16 Deferred Share Units, both economically equivalent to common shares and granted in lieu of second-quarter 2026 cash dividends. Following these awards, he holds 69,800 RSUs and 2,879 DSUs directly.

Rhea-AI Summary

Mayson Howard John reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Howard John Mayson received an award of 56 Deferred Share Units on June 30, 2026. Each Deferred Share Unit is economically equivalent to one share of Ovintiv common stock and accrues additional units as dividend equivalents. Following this grant, Mayson holds 10,084 Deferred Share Units directly, which will generally remain outstanding until his retirement from the Board.

Rhea-AI Summary

Shaw Brian Gordon reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Brian Gordon Shaw received a grant of 208 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. These DSUs were issued as dividend equivalent DSUs in lieu of cash dividends for the second quarter of 2026.

Following this award, Shaw holds a total of 37,784 DSUs directly. The DSUs generate additional dividend equivalent DSUs over time and are held until his retirement from the Board, so this filing reflects a routine, compensation-related increase rather than an open-market share purchase or sale.

Rhea-AI Summary

Ovintiv Inc. director Terri Gay King received 3 Deferred Share Units (DSUs), a compensation-related award recorded as an acquisition of derivative securities. Each DSU is economically equivalent to one share of Ovintiv common stock and accrues dividend-equivalent DSUs. After this grant, King holds 410 DSUs, which are retained until retirement from the Board.

Rhea-AI Summary

Ovintiv Inc. director Ralph Izzo reported compensation-related equity activity. On May 21, 2026, 3,510 Restricted Share Units (RSUs) vested and were settled into 3,510 shares of Ovintiv common stock on a one-for-one basis, and he received a new grant of 3,510 RSUs. Following these transactions, he directly holds 20,515 common shares. These were derivative exercises and awards, not open-market purchases or sales.

Rhea-AI Summary

Ovintiv Inc. director Howard John Mayson reported compensation-related equity activity. On May 21, 2026, he exercised 3,510 Restricted Share Units (RSUs) into 3,510 shares of Ovintiv common stock, converting RSUs on a one-for-one basis.

On the same date, he also received a new grant of 3,510 RSUs, each economically equivalent to one Ovintiv common share and yielding dividend-equivalent RSUs under the Omnibus Incentive Plan. Following these transactions, he directly holds 49,290 shares of common stock and 3,510 RSUs. No open‑market purchases or sales were reported in this filing.

Rhea-AI Summary

Ovintiv Inc. director George Pita reported compensation-related equity activity. He exercised 3,510 Restricted Share Units (RSUs) into 3,510 shares of common stock, bringing his direct common share holdings to 26,597. On the same date, he also received a new grant of 3,510 RSUs, which each represent one share of common stock and accrue dividend-equivalent RSUs.

Rhea-AI Summary

Ovintiv Inc. director Gregory P. Hill exercised restricted share units into common stock and received a new award. On May 21, 2026, he converted 3,218 Restricted Share Units into 3,218 shares of common stock and was granted a new award of 3,218 RSUs, all held directly.

Rhea-AI Summary

Ovintiv Inc. director Steven W. Nance reported equity compensation activity involving Restricted Share Units (RSUs) and common stock. On May 21, 2026, he exercised 5,704 RSUs, which settled into 5,704 shares of Ovintiv common stock, increasing his direct common stock holdings to 42,336 shares.

The same day, he received a new grant of 5,704 RSUs, each economically equivalent to one Ovintiv common share and providing dividend-equivalent RSUs. These RSUs vest and convert into common stock on a one-for-one basis under Ovintiv’s Omnibus Incentive Plan and the applicable grant agreement.

Rhea-AI Summary

Ovintiv Inc. director Brian Gordon Shaw reported compensation-related share movements tied to Restricted Share Units (RSUs). On May 21, 2026, 3,505 RSUs, each equivalent to one Ovintiv common share, settled into common stock on a one-for-one basis, with dividend-equivalent RSUs also included.

To cover tax obligations, 1,683 common shares were withheld by Ovintiv at a price of $82.46 per share rather than sold in the open market. After these transactions, Shaw directly holds 64,877 Ovintiv common shares. The RSUs were valued at CAD$82.25 per unit based on the volume-weighted average price on the Toronto Stock Exchange, and the price was converted using the Bank of Canada exchange rate.

Rhea-AI Summary

Ovintiv Inc. director Thomas G. Ricks reported equity compensation movements rather than open-market trades. On May 21, 2026, he exercised 3,510 Restricted Share Units (RSUs) into 3,510 shares of common stock, bringing his direct holdings to 103,842 shares. On the same date, he received a new grant of 3,510 RSUs, each economically equivalent to one Ovintiv common share and eligible for dividend-equivalent RSUs, vesting under the company’s Omnibus Incentive Plan.

Rhea-AI Summary

Ovintiv Inc. director Terri Gay King exercised 3,510 Restricted Share Units (RSUs) into 3,510 shares of common stock and received a new 3,510 RSU award. The RSUs convert into Ovintiv common stock on a one-for-one basis and yield dividend equivalent RSUs.

After the transactions on May 21, 2026, King directly holds 8,552 shares of Ovintiv common stock and 3,510 RSUs. These events reflect routine equity compensation activity rather than open‑market buying or selling.

Rhea-AI Summary

Ovintiv Inc. director Meg Gentle reported routine equity compensation activity. On May 21, 2026, she exercised 3,510 Restricted Share Units (RSUs), which settled into 3,510 shares of Ovintiv common stock on a one-for-one basis. Following this exercise, her direct common stock holdings rose to 32,188 shares.

On the same date, she received a new grant of 3,510 RSUs, each economically equivalent to one share of Ovintiv common stock and eligible for dividend equivalent RSUs. These RSUs vest and convert into common shares under Ovintiv’s Omnibus Incentive Plan and the related grant agreement.

Rhea-AI Summary

Ovintiv Inc. director Sippy Chhina reported equity compensation activity on May 21, 2026. Chhina received a grant of 3,505 Restricted Share Units, which were settled one-for-one into 3,505 shares of common stock. Of these, 1,739 shares were withheld by Ovintiv at $82.25 per share to satisfy tax withholding obligations, with the balance delivered as stock-based compensation.

Rhea-AI Summary

Shaw Brian Gordon reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Brian Gordon Shaw received a grant of 414 Deferred Share Units (DSUs) on common stock equivalents. These DSUs, which are the economic equivalent of one Ovintiv common share each and accrue dividend-equivalent DSUs, will be held until his retirement from the Board, bringing his direct DSU holdings to 37,576.

Rhea-AI Summary

Gentle Meg reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Meg Gentle received a grant of 493 Deferred Share Units, or DSUs, which are derivative securities tied to Ovintiv common stock. Each DSU is the economic equivalent of one common share and accrues dividend-equivalent DSUs over time.

After this award, Gentle holds 11,832 DSUs directly. These DSUs are held until retirement from the Board, so they function as long-term, stock-based compensation that aligns director pay with shareholder value.

Rhea-AI Summary

King Terri Gay reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Terri Gay King received a grant of 407 Deferred Share Units (DSUs). Each DSU is the economic equivalent of one share of Ovintiv common stock and also earns dividend-equivalent DSUs. The award was granted at $0.00 per unit as director compensation.

After this grant, King holds 407 DSUs, all reported as directly owned. DSUs are designed for long-term alignment, as they are held until the director retires from the Board, at which point they can typically be settled into common shares.

Rhea-AI Summary

Chhina Sippy reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Sippy Chhina received a grant of 414 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. Following this award, Chhina holds a total of 2,769 DSUs. The DSUs accumulate dividend-equivalent units and are held until retirement from the Board.

Rhea-AI Summary

IZZO RALPH reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Ralph Izzo reported a grant of 407 Deferred Share Units (DSUs), each economically equivalent to one share of Ovintiv common stock. After this award, he holds 7,299 DSUs directly. These DSUs also receive dividend equivalent DSUs and are held until his retirement from the Board.

Rhea-AI Summary

Shaw Brian Gordon reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Brian Gordon Shaw received 180 Deferred Share Units (DSUs) as a grant tied to first-quarter 2026 cash dividends. Each DSU is economically equivalent to one share of Ovintiv common stock and accrues dividend equivalents. After this award, he holds 37,162 DSUs, which are retained until retirement from the Board.

Rhea-AI Summary

Mayson Howard John reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Mayson Howard John received 48 Deferred Share Units as compensation. These DSUs are the economic equivalent of 48 shares of Ovintiv common stock and were received as dividend equivalent DSUs for the first quarter of 2026. Following this grant, John holds 10,028 Deferred Share Units directly. The DSUs yield dividend equivalents and are held until retirement from the Board.

Rhea-AI Summary

Gentle Meg reported acquisition or exercise transactions in this Form 4 filing.

Ovintiv Inc. director Meg Gentle received a grant of 55 Deferred Share Units (DSUs) on March 31, 2026 as a compensation-related award. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs. These units are held until retirement from the Board.

The award represents dividend-equivalent DSUs issued in lieu of cash dividends for the first quarter of 2026 and increases Gentle’s direct DSU holdings to 11,339 units, aligning her compensation further with shareholder outcomes rather than being an open-market share purchase or sale.

Rhea-AI Summary

Ovintiv Inc. executive Meghan Nicole Eilers received a compensation-related grant of 230 Restricted Share Units, or RSUs, tied to first-quarter 2026 dividends. Each RSU is economically equivalent to one share of Ovintiv common stock and also yields dividend-equivalent RSUs.

After this grant, Eilers directly holds 46,692 RSUs representing the right to receive an equal number of common shares. These RSUs vest and become exercisable under Ovintiv’s Omnibus Incentive Plan and the related grant agreement, subject to her continued employment through the applicable exercise dates.

Rhea-AI Summary

Ovintiv Inc. director Peter A. Dea received a grant of 264 Deferred Share Units (DSUs). The award is classified as a grant or other acquisition of a derivative security and is compensation-related rather than an open-market share purchase.

Each DSU is the economic equivalent of one share of Ovintiv common stock and earns dividend-equivalent DSUs. These DSUs are held until retirement from the Board. Following this grant, Dea directly holds 54,283 DSUs tied to Ovintiv common stock.